10-87863560-T-G

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2

The ENST00000692337.1(MLDHR):​c.2T>G​(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.0000156 in 383,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000022 ( 0 hom. )

Consequence

MLDHR
ENST00000692337.1 start_lost

Scores

2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 4.25

Publications

2 publications found
Variant links:
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
KLLN (HGNC:37212): (killin, p53 regulated DNA replication inhibitor) The protein encoded by this intronless gene is found in the nucleus, where it can inhibit DNA synthesis and promote S phase arrest coupled to apoptosis. The expression of this DNA binding protein is upregulated by transcription factor p53. [provided by RefSeq, Dec 2012]
KLLN Gene-Disease associations (from GenCC):
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 4
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTENNM_000314.8 linkc.-910T>G upstream_gene_variant ENST00000371953.8 NP_000305.3
KLLNNM_001126049.2 linkc.-1073A>C upstream_gene_variant ENST00000445946.5 NP_001119521.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MLDHRENST00000692337.1 linkc.2T>G p.Met1? start_lost Exon 1 of 1 ENSP00000509326.1
PTENENST00000371953.8 linkc.-910T>G upstream_gene_variant 1 NM_000314.8 ENSP00000361021.3
KLLNENST00000445946.5 linkc.-1073A>C upstream_gene_variant 6 NM_001126049.2 ENSP00000392204.2

Frequencies

GnomAD3 genomes
AF:
0.00000660
AC:
1
AN:
151628
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000216
AC:
5
AN:
231838
Hom.:
0
Cov.:
0
AF XY:
0.0000255
AC XY:
3
AN XY:
117842
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
6532
American (AMR)
AF:
0.00
AC:
0
AN:
6876
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8514
East Asian (EAS)
AF:
0.000136
AC:
3
AN:
22106
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2732
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
20332
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1226
European-Non Finnish (NFE)
AF:
0.0000135
AC:
2
AN:
148302
Other (OTH)
AF:
0.00
AC:
0
AN:
15218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000660
AC:
1
AN:
151628
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74052
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41308
American (AMR)
AF:
0.00
AC:
0
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5082
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4798
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10554
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67872
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 22, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: PTEN c.-910T>G is located in the untranscribed region upstream of the PTEN gene region. The variant was absent in 31172 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.-910T>G has been reported in the literature in individuals affected with Familial adenomatous polyposis, however this patient also carried a pathogenic APC variant (Kim_2019). This report does not provide unequivocal conclusions about association of the variant with Cowden Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 31269945). ClinVar contains an entry for this variant (Variation ID: 488768). Based on the evidence outlined above, the variant was classified as uncertain significance. -

not provided Uncertain:1
Oct 31, 2016
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is denoted PTEN c.-910T>G, and describes a nucleotide substitution 910 base pairs upstream of the ATG translational start site in the PTEN promoter region. The surrounding sequence, with the base that is substituted in brackets, is GTGA[T/G]GTGG. This variant, also called c.-909T>G using alternate numbering, has not been published in the literature to our knowledge. Variants within the PTEN promoter have been observed in individuals with features of Cowden syndrome (Zhou 2003). Based on currently available information, it is unclear whether PTEN c.-910T>G is pathogenic or benign. We consider it to be a variant of uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
22
DANN
Benign
0.88
PhyloP100
4.2
PromoterAI
-0.20
Neutral
Mutation Taster
=290/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs550385924; hg19: chr10-89623317; API